Tianjin, China

Xiuwen Sui

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Cansino Biologics Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiuwen Sui. Retrieved from https://idiyas.com/inventor/xiuwen-sui

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Xiuwen Sui

Introduction

Xiuwen Sui is a notable inventor based in Tianjin, China. He has made significant contributions to the field of biotechnology, particularly in vaccine development. His work has been recognized for its potential impact on public health.

Latest Patents

Xiuwen Sui holds a patent titled "Carrier Protein Subjected to Site-Directed Mutation and Use Thereof in Preparation of Vaccine." This innovative approach aims to enhance the efficacy of vaccines, showcasing his commitment to advancing medical science. He has 1 patent to his name.

Career Highlights

Sui is currently employed at CanSino Biologics Inc., a company known for its focus on vaccine research and development. His role at the company allows him to work on cutting-edge projects that aim to address global health challenges.

Collaborations

Throughout his career, Xiuwen Sui has collaborated with esteemed colleagues such as Tao Zhu and Zhihong Yan. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Xiuwen Sui's contributions to vaccine development and his innovative patent reflect his dedication to improving public health through science. His work continues to inspire future advancements in biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…